Tag Archive: Adela Ben-Yakar RSS

“Parkinsonian” Worms May Hold the Key to Identifying Drugs for Parkinson’s Disease, Says Scientist

“Parkinsonian” Worms May Hold the Key to Identifying Drugs for Parkinson’s Disease, Says Scientist

Researchers at The University of Texas at Austin have devised a simple test, using dopamine-deficient worms, for identifying drugs that may help people with Parkinson’s disease.

Faculty Awarded NIH Grants to Study Prevention and Treatment of Neurodegenerative and Vascular Diseases

Faculty Awarded NIH Grants to Study Prevention and Treatment of Neurodegenerative and Vascular Diseases

The National Institutes of Health (NIH) has awarded researchers at The University of Texas at Austin two highly competitive research grants to create novel therapeutics for treating heart disease as well as to develop technology that significantly reduces the time and costs required to test drugs for neurodegenerative disease.

Engineers Receive $3.2 Million in National Science Foundation CAREER Awards

Eight engineering assistant professors at The University of Texas at Austin have been awarded Faculty Early Career Development (CAREER) awards from the National Science Foundation, an honor which recognizes promising young faculty and supports their research with five years of funding.

Laser Surgery Probe Targets Individual Cancer Cells

Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser "microscalpel" that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases.

Nanosurgery on a Specially Designed Microchip Reveals Anesthetics Interfere with Nerve Regeneration Process

Nanosurgery on a Specially Designed Microchip Reveals Anesthetics Interfere with Nerve Regeneration Process

A hair strand-thin worm is providing substantial clues on how nerves regenerate, offering insight and hope to finding genes that affect nerve generation and ultimately new drugs and therapies for human neurodegenerative diseases such as Parkinson's or Alzheimer's.